Global Pharmaceuticals & Biotech Mid-Large Cap Stocks

BrightGene Bio-Medical Technology

Market Cap: CN¥21.0b

A pharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products in China.

Chongqing Genrix Biopharmaceutical

Market Cap: CN¥10.6b

A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs in China.

LigaChem Biosciences

Market Cap: ₩4.0t

A clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs.

CanSino Biologics

Market Cap: HK$12.1b

Develops, manufactures, and commercializes vaccines in the People’s Republic of China.

Alphamab Oncology

Market Cap: HK$8.6b

A clinical stage biopharmaceutical company, engages in the research, development, manufacture, and commercialization of oncology biologics.

Genscript Biotech

Market Cap: HK$23.8b

An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.

InnoCare Pharma

Market Cap: HK$23.2b

A biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases in China.

Keymed Biosciences

Market Cap: HK$11.6b

A biotechnology company, focuses on in-house discovery and development of biological therapies in the autoimmune and oncology therapeutic areas.

Piramal Pharma

Market Cap: ₹273.3b

Operates as a pharmaceutical company in North America, Europe, Japan, India, and internationally.

Mabwell (Shanghai) Bioscience

Market Cap: CN¥8.4b

A biopharmaceutical company, engages in the research and development, manufacture, and commercialization of biological products in China and internationally.

InventisBio

Market Cap: CN¥13.6b

A clinical stage biotech company, engages in the discovery and development of therapeutics for cancer and metabolic diseases in China and the United States.

Sierra Oncology

Market Cap: US$1.3b

Sierra Oncology, Inc., a late-stage biopharmaceutical company, engages in researching, developing, and commercializing therapies for the treatment of patients with hematology and oncology needs.

Dyne Therapeutics

Market Cap: US$1.4b

A clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States.

Ultragenyx Pharmaceutical

Market Cap: US$3.5b

A biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Europe, the Middle East, Africa, and the Asia-Pacific.

Ocular Therapeutix

Market Cap: US$1.2b

A biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditions using its bioresorbable hydrogel-based formulation technology in the United States.

Harrow

Market Cap: US$1.0b

An eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products.

Blueprint Medicines

Market Cap: US$6.7b

A precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally.

Zai Lab

Market Cap: US$3.5b

A biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.

Protagonist Therapeutics

Market Cap: US$2.9b

A biopharmaceutical company, develops peptide therapeutics for hematology and blood disorders, and inflammatory and immunomodulatory diseases.

Aurinia Pharmaceuticals

Market Cap: US$1.1b

A biopharmaceutical company that engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs.

Verona Pharma

Market Cap: US$6.8b

A biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs.

Kymera Therapeutics

Market Cap: US$2.0b

A clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system.

Avidity Biosciences

Market Cap: US$3.8b

A biopharmaceutical company, engages in the delivery of RNA therapeutics called antibody oligonucleotide conjugates (AOCs).

Edgewise Therapeutics

Market Cap: US$1.6b

A biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle disorders.

Twist Bioscience

Market Cap: US$1.9b

Manufactures and sells synthetic DNA-based products.

Immunovant

Market Cap: US$2.5b

A clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases.

ChemoMetec

Market Cap: DKK 9.2b

Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.

Alkermes

Market Cap: US$5.2b

A biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally.

Crinetics Pharmaceuticals

Market Cap: US$2.9b

A clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.

Biohaven

Market Cap: US$1.7b

Biohaven Ltd. discovers, develops, and commercializes therapies for immunology, neuroscience, and oncology worldwide.

Nuvalent

Market Cap: US$5.4b

A clinical-stage biopharmaceutical company, engages in the development of therapies for patients with cancer.

Sotera Health

Market Cap: US$3.6b

Provides sterilization, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.

Charles River Laboratories International

Market Cap: US$7.0b

Charles River Laboratories International, Inc.

Alvotech

Market Cap: US$3.0b

Through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide.

Natera

Market Cap: US$21.1b

A diagnostics company, provides molecular testing services worldwide.

Amneal Pharmaceuticals

Market Cap: US$2.3b

A global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products worldwide.